|
Search
Collections
Benchmarks
Upload document
Product
Kedrion IVIG 10%
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
1 indication
Indication
Primary Immunodeficiency Disease
Clinical trial
A Phase III, Open-label, Prospective, Multicenter Study to Assess Efficacy, Safety, and Pharmacokinetics of Kedrion Intravenous Human Normal Immunoglobulin (IVIg) 10% in Pediatric Patients Affected by Primary Immunodeficiency Disease (PID)
Status: Recruiting
, Estimated PCD: 2026-04-30